Optiver Holding B.V. Buys New Position in HCA Healthcare, Inc. (NYSE:HCA)

Optiver Holding B.V. acquired a new position in HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 199 shares of the company’s stock, valued at approximately $54,000.

A number of other large investors have also bought and sold shares of the company. Stone House Investment Management LLC bought a new stake in HCA Healthcare during the third quarter worth about $25,000. Centerpoint Advisors LLC bought a new stake in HCA Healthcare during the fourth quarter worth about $27,000. Atlantic Edge Private Wealth Management LLC purchased a new position in HCA Healthcare during the 4th quarter valued at about $27,000. Bruce G. Allen Investments LLC bought a new stake in HCA Healthcare during the 4th quarter valued at approximately $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC bought a new stake in HCA Healthcare during the 3rd quarter valued at approximately $30,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

Shares of HCA traded up $4.60 during trading hours on Wednesday, reaching $336.60. 377,052 shares of the company’s stock traded hands, compared to its average volume of 1,080,122. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $340.00. The firm has a market capitalization of $88.16 billion, a price-to-earnings ratio of 16.55, a P/E/G ratio of 1.54 and a beta of 1.69. The business’s fifty day simple moving average is $318.90 and its two-hundred day simple moving average is $309.01.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping the consensus estimate of $5.01 by $0.35. The firm had revenue of $17.34 billion during the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same period in the previous year, the company earned $4.93 EPS. Analysts predict that HCA Healthcare, Inc. will post 20.86 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.78%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s payout ratio is 13.16%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Chad J. Wasserman sold 876 shares of the firm’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the transaction, the senior vice president now owns 1,576 shares in the company, valued at approximately $520,474. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, EVP Michael S. Cuffe sold 1,600 shares of the business’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Chad J. Wasserman sold 876 shares of the business’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $330.25, for a total value of $289,299.00. Following the completion of the sale, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at $520,474. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,617 shares of company stock valued at $4,321,986. 1.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

HCA has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research report on Friday, April 12th. Wells Fargo & Company lifted their price target on shares of HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 28th. Robert W. Baird initiated coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective for the company. Cantor Fitzgerald reissued an “overweight” rating and set a $335.00 price target on shares of HCA Healthcare in a report on Wednesday, April 10th. Finally, StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Friday, May 31st. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $325.59.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.